![](https://endpts.com/wp-content/uploads/2023/02/Gina-Chapman-CARGO-tile.jpg)
Gina Chapman, CARGO Therapeutics CEO
Cell therapy biotech from Stanford CAR-T leader Crystal Mackall nabs $200M for PhII
A biotech born out of the work of Stanford CAR-T leader Crystal Mackall is publicly unveiling its $200 million Series A Wednesday, after already going …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.